Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast: a single-center, phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples